153390-61-5

Basic information

• Product Name: 1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine
• Synonyms: 1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine;2-[3-(Trifluoromethyl)phenyl]propan-2-amine hydrochloride;2-[3-(TRIFLUOROMETHYL)PHENYL]PROPAN-2-AMINE;1-methyl-1-[3-(trifluoromethyl)phenyl]ethylamine hydrochloride
• CAS NO: 153390-61-5
• Molecular Formula: C₁₀H₁₂F₃N
• Molecular Weight: 239.6651296
• Mol File: 153390-61-5.mol

Chemical Properties

• Boiling Point: 196.8±35.0 °C(Predicted)
• Appearance: /
• Density: 1.149±0.06 g/cm3(Predicted)
• PKA: 9.04±0.10(Predicted)
• CAS DataBase Reference: 1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine(153390-61-5)
• EPA Substance Registry System: 1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine(153390-61-5)

Safety Data

• Hazardous Substances Data: 153390-61-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine is used as a building block for the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be incorporated into the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 1-(3-TrifluoroMethylphenyl)-1-MethylethylaMine serves as a key component in the synthesis of agrochemicals. Its properties make it suitable for the creation of compounds that can be used in crop protection and other agricultural applications, enhancing the efficiency and effectiveness of these products.

Upstream product

• 368-77-4 3-trifluoromethylbenzonitrile 
• 917-54-4 methyllithium 

Downstream Products

• 959133-22-3 2-[4-(3-fluorobenzyl)-3-(2-hydroxyphenyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[1-methyl-1-(3-trifluoromethyl-phenyl)ethyl]-acetamide 
• 959139-24-3 2-chloro-N-{1-methyl-1-[3-(trifluoromethyl)phenyl]ethyl}acetamide 
• 959131-42-1 2-[3-(4-chlorophenyl)-4-cyclopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-{1-methyl-1-[3-(trifluoromethyl)phenyl]ethyl}acetamide 
• 959133-15-4 2-[3-(5-chlorothiophen-2-yl)-4-(2-fluorobenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-N-[1-methyl-1-(3-trifluoromethyl-phenyl)ethyl]-acetamide 

Relevant articles and documents

Substituted Arylimidazolone and Triazolone as Inhibitors of Vasopressin Receptors

The present application relates to novel, substituted 4-arylimidazol-2-ones and 5-aryl-1,2,4-triazolones, processes for the production thereof, the use thereof alone or in combinations for the treatment and/or prevention of diseases and the use thereof for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular diseases.

HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.

TRICYCLIC INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ALZHEIMER’S DISEASE

The present invention relates to novel hydroxyethylamine compounds having Asp2 (β-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated β- amyloid levels or β-amyloid deposits, particularly Alzheimer's disease.